IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Royalty Pharma Sub-Manager, LLC

Q4 2025 Holdings

Filed 2026-04-01 | 4 holdings | $171.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-08-21) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics, Inc(CYTK)COM23282W605$62.3M980,39236.4%
Zenas Biopharma, Inc.(ZBIO)ACOM98937L105$45.9M1,263,15026.8%
Zenas Biopharma, Inc.(BCAX)COM055477103$45.9M1,263,15026.8%
Biohaven LTD(BHVN)COMG1110E107$33.2M2,936,50719.4%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$30.0M3,846,15417.5%